Research Article RELATIONSHIP OF C-REACTIVE PROTEIN, URIC ACID, LIPID PROFILE WITH TYPE 2 DIABETES MELLITUS IN TRINIDAD

Similar documents
Controlling Lipids AIDS in the Prevention of Type 2 Diabetes, Hypertension, and Cardiovascular Diseases

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

A Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Type 2 Diabetis Mellitus

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Chapter 18. Diet and Health

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus

Frequency of Dyslipidemia and IHD in IGT Patients

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

Low HDL-levels: leave it or treat it?

Correlation of novel cardiac marker

LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME

JMSCR Vol 05 Issue 05 Page May 2017

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Diabetes Mellitus: A Cardiovascular Disease

SCIENTIFIC STUDY REPORT

2.0 Synopsis. Choline fenofibrate capsules (ABT-335) M Clinical Study Report R&D/06/772. (For National Authority Use Only) Name of Study Drug:

Metabolic Syndrome.

Rick Fox M.A Health and Wellness Specialist

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009

Total risk management of Cardiovascular diseases Nobuhiro Yamada

What is Diabetes Mellitus?

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

Lipoprotein Particle Profile

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

The Metabolic Syndrome: Is It A Valid Concept? YES

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Echocardiography analysis in renal transplant recipients

International Journal of Pharma and Bio Sciences

Morbidity & Mortality from Chronic Kidney Disease

Gender-Based and Age-Related Peculiarities of Lipid Metabolism in Chronic Heart Failure Secondary to Overweight and Obesity

Welcome and Introduction

International Journal of Research and Development in Pharmacy and Life Sciences. Research Article

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Clinical Approach to Achieving Treatment Targets: Case Vignette Discussion

Oral Disease as a Risk Factor for Acute Coronary Syndrome Single Center Experience

The Framingham Coronary Heart Disease Risk Score

Functional Blood Chemistry & CBC Analysis

Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital

Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care

Clinical Recommendations: Patients with Periodontitis

Disclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

The Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community

ISCHEMIC HEART DISEASE: Role of Total Cholesterol: HDL C Ratio as an Important Indicator Compared to LDL C.

REAGENTS. RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING

3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.

Proven and Proposed Cardiovascular Benefits of Soyfoods

Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication

Hae Sun Suh, B.Pharm., Ph.D. Jason N. Doctor, Ph.D.

Supplementary Online Content

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Chemistry Reference Ranges and Critical Values

Chemistry Reference Ranges and Critical Values

1. Which one of the following patients does not need to be screened for hyperlipidemia:

ΛΟΙΜΩΞΗ HIV. Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική

Metabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL

Effects of a dietary intervention to reduce saturated fat on markers of inflammation and cardiovascular disease.

and Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD

STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators

Ο ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη

Serum lipid profile of obese and overweight Sudanese over 60 years

Life Science Journal 2018;15(12)

Catechins Green Tea Clones GMB4 Inhibit Inflammation Process of Atherosclerosis Through Decreasing TNF-Α Levels. *

Comparison of Glucose & Lipid Profiles in Oxidative Stress Contain Diabetic Patients

Prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus patients in a tertiary care hospital of Bihar

Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with

Association of Uric acid with type II diabetes

AGING KIDNEY IN HIV DISEASE

Patients with the metabolic syndrome are at increased risk

DECLARATION OF CONFLICT OF INTEREST. None

The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema

A replacement KAMUT khorasan wheatbased diet improves the risk profile of patients with type 2 diabetes mellitus (T2DM): a randomized cross-over trial

Cardiovascular Disease After Spinal Cord Injury: Achieving Best Practice. Suzanne Groah, MD, MSPH Walter Reed Army Medical Center February 12, 2010

DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul Rashid

Uric acid and CKD. Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George

Study of fixed dose combination for the management of cardiovascular diseases

This information is intended to be used with the help of a relevant health professional, and is available as a booklet to download.

What is the evidence that dietary components can act on the microbiome and influence health?

Supplementary Online Content

Metabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI

Macrovascular Management. What s next beyond standard treatment?

Diabetic Dyslipidemia

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk?

DIABETES. A growing problem

Treating the Cause to Prevent and Reverse Heart Disease. Caldwell B. Esselstyn Jr., M.D.

Cardiovascular Risk Factors among Diabetic Patients Attending a Nigerian Teaching Hospital. O Alao, S Adebisi, G Jombo, D Joseph, O Damulak, F Puepet

Transcription:

International Journal of Research and Development in Pharmacy and Life Sciences Available online at http//www.ijrdpl.com February - March, 2015, Vol. 4, No.2, pp 1451-1455 ISSN (P): 2393-932X, ISSN (E): 2278-0238 Research Article RELATIONSHIP OF C-REACTIVE PROTEIN, URIC ACID, LIPID PROFILE WITH TYPE 2 DIABETES MELLITUS IN TRINIDAD B S Nayak*, D Brennen, S Narine, A Rampersad, J Sinanan, R Dilbar, R Singh, S Khan, S Ali, V Lowe, S Maharaj The University of the West Indies, Faculty of Medical Sciences, Department of Preclinical Sciences, Trinidad and Tobago *Corresponding Author: Email shiv25@gmail.com (Received: December 10, 2014; Accepted: January 27, 2015) ABSTRACT Objectives: To examine the relationship of C-reactive protein (CRP), lipid profile, uric acid, age and gender in subjects with type 2 diabetes and to determine whether there are links between these variables and disease manifestations. Methods and materials: A retrospective study comprised 206 patients from two major hospitals of Trinidad and Tobago with (67) and without (139) diabetes. Results: There were 117 females (57%) and the majority of participants were Indo-Trinidadians (60.7%). The diabetic subjects had elevated C-reactive protein (0.95 mg/l±1.6), uric acid (6.0 ± 2.1), triglycerides (155.53 ± 82.14) and LDL cholesterol (123.35± 51.84) when compared to non-diabetic population with CRP (0.48 mg/l± 0.56) uric acid (5.66 ± 2.47), triglycerides (138.39 ±72.22) and LDL-cholesterol (117.36 ± 35.50). The incidence of diabetes showed a normal distribution, increasing with age and peaking in the 50-59 age groups. An association was observed between uric acid and lipid profile in diabetic subjects. After adjustment for age and gender, in the diabetic population with an elevated CRP, a direct relationship was observed between uric acid and cholesterol levels as the same patients show marked elevations in both categories. Conclusions: Our study did not found any useful predictors for CRP and diabetic subjects. The CRP levels within the participants fluctuated to a great extent and showed no correlation with increased uric acid, lipid profile or diabetic status. Keywords: CRP; diabetes; age; gender; lipid profile. INTRODUCTION Diabetes mellitus is due to absolute or relative insulin deficiency. It has been defined by the World Health Organization (WHO), as a fasting plasma venous glucose concentration greater than 7.8mmol/litre (140mg/dl) or a concentration of 11.1 mmol/l (200mg/dl) or more, two hours after a carbohydrate meal or two hours after oral ingestion of the equivalent of 75g of glucose, even if the fasting concentration is normal (1). Diabetes mellitus is one of the most common chronic diseases worldwide. According to WHO, diabetes mellitus ranks numbers eight and ten as the leading causes of death in high income and middle-income countries respectively (2). This research project focuses on type 2 diabetes mellitus and C - reactive protein. C-reactive protein (CRP) is produced by the liver and found in the blood but are considerably low in the blood of healthy persons. After an injury, infection, or inflammation they become elevated and last for the duration. Once healed, or the infection or inflammation goes away the CRP present in the blood diminishes. Inflammation, according to a study conducted by Greenfield and Campbell is suggested to be a cause of insulin resistance and type 2 diabetes mellitus as indicated by the elevated levels of CRP in the blood (3). SRDE Group, All Rights Reserved. Int. J. Res. Dev. Pharm. L. Sci. 1451

B. S. Nayak et. al., February - March, 2015, 4(2), 1451-1455 Lipid profile is a group of tests ordered to determine a person s risk of coronary heart disease. A person with diabetes abnormal lipid profile is referred to as diabetic dyslipidemia. Patients with type 2 diabetes have an atherogenic lipid profile (4) with the characteristics of this condition being: HDL-C - low levels ( 35mg/dl), LDL-C - relatively normal and triglyceride - high levels ( 250mg/dl). Uric acid is the end result of metabolism. It is poorly soluble in plasma and therefore precipitates into tissues where it crystallizes in joints especially those in the feet leading to a condition known as gout. Gout is an inflammatory response and would lead to the release of C- reactive proteins into the blood. An increase in serum uric acid is seen in cases of increased insulin resistance, which could lead to an increase in CRP in people with type 2 diabetes. According to a study conducted by Nayak et al age was found to be a significant predictor of type 2 diabetes with a frequency of 35.6% in the 31-40 year age group compared with 73.7% in 80 years and over, suggesting and increase in risk/ prevalence of the disease with an increase in age (6). Nayak et al and the American National Diabetes fact sheet showed diabetes being more prevalent in males than females. Nayak et al findings stated that male gender increased the risk for type 2 diabetes by a significant 16% while the American National Diabetes fact sheet stated 11.8% of men and 10.8% of women within the age group 20 and over suffered with type 2 diabetes (6). According to Lakoski et al women have higher median CRP levels than men (7). National Diabetes fact sheet stated that of the adults aged 20 and above, 67% have high blood pressure. In diabetes the usual mechanism of maintaining blood pressure at normal levels, nitric oxide which is usually present in the endothelial cells of blood vessels is disrupted, hence the strong relationship between high blood pressure and diabetes. A study conducted by Smith et al concluded that CRP levels are associated with blood pressure but an elevated level does not lead to elevated blood pressure levels (8). Smith et al. (2005) and Ndumele et al (2006) conducted research on type 2 diabetes and its link with blood pressure, age, C-reactive proteins or all of the above. This research project has joined those many groups and focused on C- reactive proteins in diabetes linking it with lipid profile, uric acid and anthropometric variables. Based on research done thus far, there is an association with C-reactive protein and type 2 diabetes. In fact Greenfield and Campbell (2006) in Sydney Australia, (3) have concluded that inflammation has been an important risk factor for development of both insulin resistance and type 2 diabetes mellitus due to the elevated levels of CRP and inflammatory markers. Ndumele et al (2006) showed that inflammation and CRP levels are linked to insulin resistance, impaired insulin sensitivity and development of type 2 diabetes (9). Both of them concluded that there is in a link between CRP and diabetes. One of the factors researched in the project was the relationship between lipid profile and diabetes. With regards to the abnormal lipid profile, studies suggest that there is a link between abnormal lipid profile and diabetes. Windler E. (2005) compared and contrasted the lipid profile of non-diabetics and diabetics finding that patients with type 2 diabetes are more likely to have the atherogenic form of LDL-C than non- diabetic subjects (10). Nayak et al showed no significant difference between the mean HDL levels of diabetics and non-diabetics was seen (11). The purpose of this study is to examine the relationship of uric acid, lipid profile and anthropometric variables: age, gender and blood pressure with CRP and determine whether there is in fact a link between these variables in Trinidadian type 2 diabetics. Majority of the studies cited are of studies outside of the Caribbean. This research project intends to add to the already known information about this topic. Materials and methods The retrospective study was used to determine the link between high C-reactive protein, abnormal lipid profile, uric acid levels, gender and age in type 2 diabetic patients. The target population focused on was diabetic and non-diabetic subjects in Trinidad and Tobago with non- diabetics being used for comparison with the diabetic subjects. The data was collected from 206 patient records from San Fernando General Hospital and Eric Williams Medical Sciences Complex in Trinidad. Inclusion criteria of persons in the study were type 2 diabetics and non-diabetics for comparison, males and females between the ages of 21 and 90 of all ethnicities. SRDE Group, All Rights Reserved. Int. J. Res. Dev. Pharm. L. Sci. 1452

B. S. Nayak et. al., February - March, 2015, 4(2), 1451-1455 Exclusion criteria were the patients not meeting the above criteria, pregnant women, records dated prior to 2006, patients with complications of type 2 diabetes and inflammatory disorders that would affect the CRP levels. The primary variables collected were CRP, uric acid, lipid profile (TG, HDL-C, LDL-C, and total cholesterol), gender and age. Patients with random venous plasma glucose levels greater than 126mg/dl, who fit the inclusion criteria, were used as the diabetic patients in the study and those with normal glucose levels who also fit the inclusion criteria were used as non-diabetic patients. Data collected was organized into diabetic and non-diabetic and analyzed by the Statistical Package for the Social Sciences (SPSS) system. SPSS was used to give Descriptive and Interpretative results of the findings. Figure 1: Elevated variables of diabetic and abnormal CRP subjects compared to non-diabetic subjects with abnormal CRP. Table 1 Demographic status of the sample population Age group Total (non-diabetic/diabetic) 20-29 10 (9/1) 30-39 22 (20/2) 40-49 33 (21/12) 50-59 51 (25/26) 60-69 37 (24/13) 70-79 27 (18/9) 80-90 9 (5/4) CRP Level Abnormal 68 (40/28) Normal 139 (94/45) Gender Male 89 (51/28) Female 117 (72/39) Ethnicity Indo-Trinidadian 111 (69/42) Afro-Trinidadian 63 (44/19) Mixed 16 (10/6) Table 2 Calculated mean of all variables for the sample population Variable Mean Standard Deviation Standard Error Age CRP Uric Acid Cholesterol Triglycerides 54.680 15.382 1.072 0.651 1.065 0.074 5.818 2.348 0.163 189.233 49.179 3.426 146.057 78.375 5.460 RESULTS The number of diabetics was less in the younger age group ranging from 21-30 years (Table 1). Type 2 diabetes is more prevalent in persons 35 years and older. In observing our study population the prevalence of diabetes increased in age from 20-59, which supports data that says there is a correlation with type 2 diabetes and increasing age. Our study noted the presence of more people in 50-59 age groups when compared to all other age groups. For age and gender, females dominated the total population with 117 total subjects over the males (89 subjects). To focus on the 50-59 age groups which have the greatest prevalence of diabetes, females also dominated with 62% of that population. LDL-C 117.902 41.522 2.892 HDL-C 46.830 18.841 1.312 Our study utilized high sensitivity CRP which can detect CRP levels as low as 0.04mg/l. The CRP level of above 0.5 mg/l considered abnormal. In the sample population, 33% of subjects had an abnormal CRP level and when correlated with a diabetic status, 41% of the subjects showed a diabetic status coupled with an abnormal CRP level. Figure 2 graphically represents our target population of diabetic and non-diabetic with an abnormal CRP. Uric acid was elevated in 54% of diabetic subjects compared to 60% of the population who showed a non-diabetic status and normal CRP levels having a normal uric acid. Cholesterol levels SRDE Group, All Rights Reserved. Int. J. Res. Dev. Pharm. L. Sci. 1453

were also elevated in 54% of subjects as stated previously, in the same population with an increased uric acid. This is compared to 51% of the non-diabetic (normal CRP) population showing an either normal or low cholesterol level. The triglyceride and LDL-C levels in the target population were increased, whereas in the non-diabetic (normal CRP) population they were normal in 75% and 65% respectively. Finally, the HDL-C in our target population was decreased in 75% of subjects showing that this was the single most important variable (Table 2). DISCUSSION In this study, the relationship between C-reactive protein (CRP) and lipid-profile, along with glucose levels in diabetics, were investigated. Of the 207 subjects 60.7% were East Indian, 57% were female, and 77.6% were 50 years or older. It can therefore be seen that a person s age is a definitive marker for the prevalence of diabetes, as was expected. To focus on the 50-59 age groups which have the B. S. Nayak et. al., February - March, 2015, 4(2), 1451-1455 between elevated CRP levels and decreased insulin sensitivity, but research is still inconclusive (2). There were no useful predictors that found a correlation between C-reactive protein, diabetes mellitus, uric Acid level and an elevated lipid profile. It was conclusive that there is evidence of age being a compounding factor for Diabetes. However, CRP continues to show evidence as an inflammatory marker signaling infection once elevated and literature suggest that the manifestation of diabetes continues to be a disorder that does not illicit and inflammatory response. Acknowledgements We express our sincere thanks to Mr Shamjeet Singh, Biochemistry unit and Dr George Legall for their statistical help and staff of all the health care facilities of Trinidad and Tobago. Special thanks to the University of the West Indies, St Augustine for their valued support throughout this study. REFERENCES greatest prevalence of diabetes, females also dominated 1. Joan FZ, Peter RP, Philip DM. (1988) Clinical Chemistry with 62% of that population. This correlates with a study in Diagnosis and Treatment 5th edition pg. 211 (1988). 2. World Health Organization: The 10 leading causes of done by the Red Cross which indicated that females in the death by broad income group (2004) age group are among the greatest prevalence with the www.who.int/mediacentre/ factsheets/ fs310/en disease (12). /index.html. On analyzing the data, it can be seen that no direct 3. Greenfield JR, Campbell LV. (2006) Relationship between Inflammation, insulin resistance and type 2 relationship between elevated CRP levels and diabetes diabetes: cause or effect? Curr Diabetes. 2(2): 195- existed. CRP was found to be elevated in some diabetic 211. 4. Windler E. (2005) What is the consequence of an subjects; however there was no apparent trend and the abnormal lipid profile in patients with type 2 diabetes distribution was erratic. The occurrence of elevated CRP in or the metablolic syndrome? Atheroscler Suppl. 6(3):11- diabetic patients can therefore be considered coincidental. 14.. Observing the uric acid levels and cholesterol levels in those 5. Nayak BS, N Maharaj, Le- Ann -Fatt, G Legall. (2011) Relationship of Biochemical parameters, BMI diabetic subjects with an elevated CRP these categories show and blood pressure with age, gender and ethnicity of a total of 15 subjects each. This supports a study that found Trinidadian type 2-diabetic subjects. Archives of a correlation between elevated uric acid levels in subjects Physiology and Biochemistry. 118 (1): 10-15. who had metabolic syndrome, which includes diabetes, 6. American Diabetes Association National Diabetes Fact sheet (released January 26th 2011) elevated cholesterol and increased LDL levels (13). CRP is http://www.diabetes.org/diabetes-basics/diabetesstatistics/ an inflammatory marker and thus, may have been elevated 7. Lakoski S, Cushman M, Criqui M, Rundek T, Blumenthal due to co-existing conditions. In past studies performed, there R, D'Agostino Jr R, Herrington D. Gender and C- were demonstrated associations between elevated levels of Reactive Proteins: Results, circulating acute phase inflammatory markers, typified by www.medscape.com/viewareticle/547629_4. CRP and the development of type 2 diabetes (1). CRP has 8. Smith GD, Lawlor DA, Harbord R, Timpson N, Rumley A, Lowe GD, Day IN, Ebrahim S.(2005) Association of C- been seen to be elevated in patients suffering from reactive protein with blood pressure and hypertension: hypertension and cardiac diseases, especially myocardial life course confounding and mendelian randomization infarctions, and recent studies have shown a possible link tests of causality. Arterioscler Thromb Vasc Biol. 25:1051 1056. SRDE Group, All Rights Reserved. Int. J. Res. Dev. Pharm. L. Sci. 1454

9. Ndumele CE, Prodhan AD, Ridker PM. (2006) Interrelationships between Inflammation, C- reactive proteins and Insulin resistance. Summer, 1(3): 190-196. 10. Windler E, Schöffauer M, Christiane Zyriax B. (2007) The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular. Diabetes and Vascular Disease Research. 4: 136-142. 11. Nayak BS, Butcher DM, Bujhawan S, Chang D, Chang S, Cabral-Samaroo D, Cadan S, Buchoon V, Budhram L, Boyce M, Teelucksingh S. (2011) The Association of low serum creatinine, abnormal lipid profile, gender, age and ethnicity with Type 2 diabetes mellitus in Trinidad & Tobago. Diab Res Clin Pract. 25 (8): 1201-1208. 12. Kumar K., Fateh V., Verma B., Pandey S., Some herbal drugs used for treatment of diabetes, Int. J. Res. Dev.Pharm. L. Sci., 2014, 3(5), pp. 1116-1120. 13. Liu P, Li Y, Yu H. (1999) Relationship between diabetes mellitus, impaired glucose tolerance and age, menopause, pregnancy: a survey of 5153 women in Shenzhen. Chin Med J (Engl). 112(7): 612-614. 14. Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K. (2007) Low Urine ph: A Novel Feature of the Metabolic Syndrome. Clin J Am Soc Nephrol. 2: 883-888. B. S. Nayak et. al., February - March, 2015, 4(2), 1451-1455 How to cite your article: Nayak B. S., Brenne D., Narine S., Rampersad A., Sinanan J., Dilbar R., Singh R., Khan S., Ali S., Lowe V., Maharaj S., Relationship of c-reactive protein, uric acid, lipid profile with type 2 diabetes mellitus in trinidad, Int. J. Res. Dev. Pharm. L. Sci., 2015, 4(2), pp. 1451-1455. SRDE Group, All Rights Reserved. Int. J. Res. Dev. Pharm. L. Sci. 1455